Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 14, 2005; 11(26): 4052-4060
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4052
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4052
Figure 7 8-Iso-PGF2α levels generated in vitro upon oxidation of native LDLs by CuSO4, either in the absence (C, control) or in the presence of increasing concentrations of lansoprazole (LAN).
Each column represents the mean value obtained from 5-6 experiments±SE (vertical lines). aP < 0.05 vs the control values.
- Citation: Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, Antonioli L, Lazzeri G, Tacca MD. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 2005; 11(26): 4052-4060
- URL: https://www.wjgnet.com/1007-9327/full/v11/i26/4052.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i26.4052